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ABSTRACT 
We present two cases of cryptococcal meningitis in patients subsequently diagnosed 
with idiopathic CD4+ lymphopenia. Both presented with new onset headaches 
without sinister features and were sent home on multiple occasions from emergency 
departments. Cryptococcal meningitis in HIV-negative patients poses major 
diagnostic and management problems and the associated mortality is 9-27%. We 
suggest blood and CSF cryptococcal antigen tests are performed for all patients with 
lymphocytic meningitis. 
 
CASE 1 
A 33-year-old Irish woman with a background of juvenile idiopathic arthritis in 
remission without treatment presented to the emergency department with headaches 
but no red flag features and was discharged. She re-presented several weeks later 
with vomiting and was again discharged. Five weeks after onset she presented for a 
third time. Neurological examination was unremarkable and she was apyrexial. Initial 
investigations demonstrated a raised C-reactive protein of 68mg/L (<5mg/L) and a 
low lymphocyte count 0.2 x 109/L (1.1-4.0 x 109/L). Lumbar puncture revealed; 
opening pressure 28 cmH20, lymphocyte count 14 x 106/L, protein 0.83g/L and 
glucose 1.9mmol/L (serum 4.4mmol/L). Cryptococcus neoformans was grown from 
her blood culture and subsequently from the CSF. The cryptococcal antigen was also 
positive in blood at 1:160 and CSF at 1:1280.  
HIV serology was negative but immunological investigations revealed a CD4+ 
lymphopenia with cell count 10 x 106/L (500-1500 x 106/L). There was also a mild 
CD8+ lymphopenia that resolved on repeat testing. She had normal serum 
immunoglobulins and IgG subclasses, except for a mildly elevated serum IgA. A 
serological screen for other viral causes of lymphopenia was negative. The 
antinuclear antibody titre was 1:1280 and RNP antibody was positive raising the 
possibility of subclinical mixed connective tissue disease. T2-weighted MRI of the 
brain showed small patches of non-specific hyperintensity within the cerebral white 
matter, associated with mildly enlarged perivascular spaces and, after contrast, small 
focal enhancing lesions within the right internal capsule and left caudate nucleus 
(figure 1).  
She was an inpatient for six weeks and was treated with intravenous 
amphotericin B and flucytosine, had three lumbar punctures for CSF pressure 
monitoring (table 1) and made a full recovery. She has remained well for 12 months 
on maintenance treatment with oral fluconazole and prophylactic co-trimoxazole. 
Blood tests have continued to show CD4+ counts below 50 x 106/L. 
 
Table 1 CSF opening pressure and analyses in case 1. 
 
CASE 2 
A 48-year-old man of Pakistani descent developed headaches and photophobia after 
a cataract operation, and was discharged from three different emergency 
departments over a two-week period. He was finally admitted when he was found to 
be profoundly confused at a routine outpatient appointment. Upon transfer to the 
emergency department he required sedation and intubation due to agitation, and to 
Day Opening pressure 
(cmH20) 
White cell count 
(x 106/L) 
Protein 
(g/L) 
Cryptococcal antigen 
titre 
1 28 14 0.83 1:1280 
2 27 32 0.88 - 
4 30 20 0.71 1:80 
10 22 12 0.50 1:128 
enable further assessment. He had abused cocaine and heroin until four years 
earlier and had received treatment for tuberculosis two years previously after 
developing night sweats and cervical lymphadenopathy; a lymph node biopsy had 
shown granulomata without necrosis or acid-fast bacilli and culture was negative.  
An initial CT head showed right maxillary antral mucosal thickening only. 
Lumbar puncture revealed an opening pressure of 44 cmH20, white cell count 212 x 
106/L (75% lymphocytes), protein 0.89g/L, glucose 1.1mmol/L and no growth after 
prolonged incubation. HIV serology was negative. Intravenous aciclovir and 
ceftriaxone was initiated and anti-tuberculous therapy subsequently added. An MRI 
brain showed gyral-sulcal restricted diffusion in keeping with meningoencephaitis. 
Repeat lumbar puncture revealed a positive CSF cryptococcal antigen and 
Cryptococcus neoformans was grown.  
The patient was treated on the intensive care unit with intravenous 
amphotericin B and flucytosine for four weeks. During this time he had a persistently 
raised CSF pressure despite lumbar puncture and underwent a temporary lumbar 
drain insertion after a communicating hydrocephalus was identified on further 
imaging. Cervical and axillary lymphadenopathy was noted on examination and a 
repeat lymph node biopsy showed granulomatous inflammation with encapsulated 
yeasts in keeping with disseminated cryptococcal infection. A repeat MRI brain 
showed patchy areas of abnormal signal related to the frontal, parietal and temporal 
and insular cortices bilaterally (figure 2) without meningeal enhancement. 
Immunological investigations subsequently revealed a CD4+ lymphopenia. The 
CD56+ and CD19+ cell counts were also mildly reduced and increased, respectively. 
His lymphocyte subsets were as follows: CD3 absolute 911 x 106/L (59%), CD4 
absolute 115 x 106/L (7%), CD8 absolute 840 x 106/L (53%),CD19 absolute 526 x 
106/L (35%), CD56 absolute 80 x 106/L (5%). He had normal serum 
immunoglobulins and IgG subclasses.  
During his six-month admission he made a gradual recovery but still has 
major cognitive problems. He remains distractible and impulsive, cannot comply with 
formal cognitive testing, can follow simple commands but needs prompting to eat or 
wash. He continues to take maintenance oral fluconazole and prophylactic co-
trimoxazole. 
 
DISCUSSION 
Diagnosis was delayed in both cases, and may have contributed to the adverse 
outcomes in the second case. There is a need for increased awareness of 
cryptococcal infection in HIV-negative patients with no overt iatrogenic 
immunocompromise. 
Cryptococcal disease in the absence of HIV infection is rare, and is most 
commonly described in association with organ transplants, haematological 
malignancies, renal or liver failure and chronic steroid use. In the last 15 years there 
has been increasing recognition of a group of patients with previously unknown 
primary immunological disturbances that predispose to cryptococcal infection. These 
include idiopathic CD4+ lymphopenia, antibodies against granulocyte-macrophage 
colony stimulating factor or IFN- and monogenic disorders such as chronic 
granulomatous disease, hyperimmunoglobulin E syndromes and 
hyperimmunoglobulin IgM syndromes.[1] Idiopathic CD4+ lymphopenia (ICL) first 
described in 1992 is defined by a CD4+ count below 300 x 106/L on at least two 
occasions in the absence of HIV infection or other known immunodeficiency or 
treatment associated with lymphopenia.[2] The aetiology remains unclear, but may 
be due to defects in T-cell receptor signalling, including CXCR4 expression, and 
UNC119 gene mutations.[1] Autoimmunity is reported to occur in around 25% of 
patients, most frequently systemic lupus erythematous (SLE).[3]  
These “pseudo” immunocompetent patients present major diagnostic 
problems. Zonios et al reviewed all 53 cases of cryptococcal meningitis with ICL in 
the literature to 2007.[4] Median age was 41 years with CD4+ count 82 x 106/L(range 
7-292 x 106/L) at presentation.  Fever was present in only 42% and other 
opportunistic infections suggestive of immunodeficiency were only present in 4%.[4] 
Absence of fever introduced significant diagnostic delay as with our cases. 
Cryptococcal meningitis may be caused by C. neoformans, as in the cases 
described, or. C. gatttii. C. neoformans occurs worldwide, with infections typically 
occurring in immunocompromised individuals. C.gattii, endemic in tropical and sub-
tropical regions, has recently emerged in the Pacific northwest of North America and 
causes infection in seemingly immunocompetent individuals.[1] 
The investigation of HIV-negative cryptococcal meningitis is usually 
straightforward, but only if the diagnosis is considered. CSF white cell count and 
protein are higher and glucose is lower than in HIV patients.[5] Cryptococcal antigen 
tests are positive in the CSF of 97% and serum of 87% of all patients with 
cryptococcal meningitis. The sensitivity in serum may be lower in HIV-negative 
individuals and was 77% in a cohort of solid organ transplant recipients.[6] False 
negatives with the latex agglutination assay have been reported in patients with high 
antibody titres, due to the prozone effect, and in infection with C. gattii. A relatively 
recently developed lateral flow assay is a point of care antigen test with an improved 
sensitivity in blood and CSF, including for C. gattii, and is not subject to the prozone 
effect.[7] MRI findings are non-specific and include dilated Virchow-Robin spaces, 
pseudocysts, cryptococcomas and lacunar or cortical infarcts. Large 
cryptococommas are associated with C. gattii.[1] Referral for immunological 
investigations should also be considered following a diagnosis of cryptococcal 
infection in an HIV-negative patient. 
Treatment protocols derived from limited trials in HIV positive patients are 
covered in the 2010 guidelines from the Infectious Disease Society of America.[8] 
Treatment in HIV-positive patients is usually with amphotericin and flucytosine for at 
least two weeks. Liposomal amphotericin is preferred in HIV-negative patients 
because it is equally effective but better tolerated as treatment duration is four to six 
weeks.[1] Intravenous fluids, electrolyte replacement and a reduction in the dose of 
flucytosine may be needed in acute kidney injury to avoid bone marrow toxicity. 
Consolidation involves high dose oral fluconazole for eight weeks followed by 
maintenance therapy with lower doses usually for at least 6-12 months.[1] There is 
no clear evidence base to guide the duration of maintenance therapy, or secondary 
prophylaxis, in HIV-negative patients. Extrapolating from guidelines for HIV-infected 
patients, we recommend monitoring the CD4+ count and having a low threshold for 
continuing maintenance fluconazole (assuming no attributable side effects), and 
considering co-trimoxazole prophylaxis, if the CD4+ count remains below 100 x 
106/L.[8]  
Raised CSF pressure occurs in 19% of HIV-negative patients (median 
23cmH20),[9] and was encountered in both reported cases. This is caused by 
impaired CSF reabsorption and a communicating hydrocephalus can develop. 
Management of raised CSF pressure involves regular therapeutic lumbar punctures 
until the pressure is below 25cmH20.[1] Occasionally lumbar drain insertion is carried 
out, as in case 2. Obstructive hydrocephalus can also occur in HIV-negative patients, 
particularly in those with large cryptococcomas secondary to C. gattii infection, and 
ventricular shunting may be required. Pappas et al reported that 11% of HIV-negative 
patients with Cryptococcal meningitis required a permanent ventricular shunt.[9] 
Steroids are not routinely recommended but may have a role in large 
cryptococommas associated with oedema or in immunocompetent patients that 
develop a post-infectious inflammatory response syndrome.[8]  
Mortality in crytococcal meningitis is higher in HIV-negative patients and was 
reported as 27% by Pappas et al in 2013.[5] In the aforementioned series of ICL 
patients alone it was only 9%. The reasons behind these large differences in the two 
major series are unexplained and more recent data on mortality in ICL is lacking. 
Haematological malignancy, organ failure, absence of headache, male gender, 
altered mental status and possibly raised intracranial pressure were associated with 
increased mortality in HIV-negative patients.[1]  
 
CONCLUSION 
HIV-negative patients with cryptococcal meningitis pose diagnostic and management 
problems because these patients may have no prior history suggesting 
immunosuppression and if due to a primary immunodeficiency, immune 
reconstruction may be impossible. The high mortality in HIV-negative patients 
necessitates a low index of suspicion in patients with a new onset of headaches. We 
advocate blood and CSF cryptococcal antigen testing in all cases of lymphocytic 
meningitis. 
 
KEY POINTS 
• Cryptococcal meningitis rarely occurs in apparently immunocompetent 
patients 
• Multiple novel non-HIV immunodeficiency syndromes have been identified of 
which idiopathic CD4+ lymphopenia is the best known 
• Fever is absent in half of cases 
• Diagnostic delay is common and may contribute to mortality rates of 9-27% 
• We recommend Cryptococcal antigen testing in blood and CSF in all cases of 
lymphocytic meningitis 
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LEGENDS 
Figure 1 Axial T2-weighted MRI Brain image in case 1 showing multiple deep white 
matter nonspecific lesions.   
Figure 2 Axial T2-weighted MRI Brain image in case 2 showing patchy areas of 
abnormal signal related to the frontal, parietal and temporal and insular cortices. 
